Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Hepatocellular Carcinoma”

310 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 310 results

Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT00537121
What this trial is testing

Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer

Who this might be right for
Esophageal CancerGastric CancerLiver Cancer
Roswell Park Cancer Institute 23
Early research (Phase 1)Active Not RecruitingNCT06218511
What this trial is testing

A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute, Naples 10
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Testing effectiveness (Phase 2)UnknownNCT00054951
What this trial is testing

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads

Who this might be right for
Hepatocellular Carcinoma
FeRx 30
Early research (Phase 1)Looking for participantsNCT07364357
What this trial is testing

A Phase I Study of CREPT-618 in Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 13
Testing effectiveness (Phase 2)Looking for participantsNCT06923761
What this trial is testing

EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)

Who this might be right for
Advanced Solid Malignancy
Grey Wolf Therapeutics 300
Early research (Phase 1)UnknownNCT02719782
What this trial is testing

TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 10
Not applicableStudy completedNCT01717066
What this trial is testing

The Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma

Who this might be right for
Stage I Hepatocellular CarcinomaStage II Hepatocellular Carcinoma
ShenFeng 480
Early research (Phase 1)Looking for participantsNCT06307925
What this trial is testing

A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
HC Biopharma Inc. 122
Testing effectiveness (Phase 2)Ended earlyNCT04212221
What this trial is testing

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Zai Lab (Shanghai) Co., Ltd. 89
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Early research (Phase 1)Study completedNCT00467194
What this trial is testing

Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
National Cancer Centre, Singapore 27
Early research (Phase 1)UnknownNCT00960167
What this trial is testing

A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT01009801
What this trial is testing

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 27
Early research (Phase 1)Active Not RecruitingNCT05097911
What this trial is testing

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

Who this might be right for
Advanced Hepatocellular Carcinoma
National University Hospital, Singapore 33
Early research (Phase 1)Study completedNCT00978107
What this trial is testing

Trial of TG4023 Combined With Flucytosine in Liver Tumors

Who this might be right for
Hepatocellular Carcinoma
Transgene 16
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT01406574
What this trial is testing

Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Otsuka Pharmaceutical Co., Ltd. 23
Load More Results